TrimRx's Blog
Best Compounded Tirzepatide Provider 2026: Provider Roundup
The compounded tirzepatide market changed more than the semaglutide market in 2024 and 2025.
Best Compounded Semaglutide Provider 2026: Provider Roundup
The legitimate compounded semaglutide market in 2026 is smaller than the marketing makes it look.
Best Alternatives During Zepbound Shortage
Introduction Zepbound® is officially off the FDA shortage list, but pharmacy-level supply gaps at the 12.5 mg and 15 mg maintenance doses still hit…
Best Alternatives During Wegovy Shortage
When your pharmacy can’t fill Wegovy and the wholesaler says “two more weeks,” doing nothing isn’t a good option.
Beginner Workout Plan for GLP-1 Patients (12-Week Program)
Starting a workout routine on a GLP-1 has unique constraints.
What to Do When BCBS Blue Cross Blue Shield Denies Zepbound: Step-by-Step Appeal
Introduction Blue Cross Blue Shield denies Zepbound® through one of five patterns: PA criteria not met, non-formulary on the plan, step therapy requirement (commonly…
What to Do When BCBS Blue Cross Blue Shield Denies Wegovy: Appeal Strategy
Blue Cross Blue Shield is a federation of 33 independent licensees, and each one writes its own GLP-1 coverage policy.
Backorder GLP-1: How Long Will the Wait Be
When the pharmacy says “we have it on backorder” it could mean a few different things, and the time horizon for each is wildly different.
Back to School on GLP-1: Managing Medication as a Parent
The back-to-school transition is one of the harder seasonal shifts for parents on GLP-1 medications.
